TY - JOUR
T1 - Treatment of hepatic adenomatosis
AU - Meyer, Claire
AU - Lisker-Melman, Mauricio
N1 - Publisher Copyright:
© Springer Science+Business Media New York 2015.
PY - 2015/6/1
Y1 - 2015/6/1
N2 - Hepatic adenomatosis and hepatocellular adenomas share risk factors and the same pathophysiologic spectrum. The presence in the liver of 10 hepatocellular adenomas defines hepatic adenomatosis. The diagnosis may be established incidentally during a liver radiologic examination in the asymptomatic patient, or after associated right upper quadrant pain, hepatomegaly or liver test abnormalities. Upon the diagnosis of hepatic adenomatosis or either of its lifethreatening complications—hemorrhage and progression to hepatocellular carcinoma—consideration should be given to potential medical, radiologic, and surgical interventions including observation (estrogen and androgen withdrawal), resection, transarterial embolization, radiofrequency ablation, and liver transplantation. The management of patients with hepatic adenomatosis can be challenging. These patients should be ideally referred to centers with expertise in the management of liver diseases.
AB - Hepatic adenomatosis and hepatocellular adenomas share risk factors and the same pathophysiologic spectrum. The presence in the liver of 10 hepatocellular adenomas defines hepatic adenomatosis. The diagnosis may be established incidentally during a liver radiologic examination in the asymptomatic patient, or after associated right upper quadrant pain, hepatomegaly or liver test abnormalities. Upon the diagnosis of hepatic adenomatosis or either of its lifethreatening complications—hemorrhage and progression to hepatocellular carcinoma—consideration should be given to potential medical, radiologic, and surgical interventions including observation (estrogen and androgen withdrawal), resection, transarterial embolization, radiofrequency ablation, and liver transplantation. The management of patients with hepatic adenomatosis can be challenging. These patients should be ideally referred to centers with expertise in the management of liver diseases.
KW - Hepatic adenomatosis
KW - Liver adenomatosis
KW - Management of liver adenomatosis
KW - Treatment of hepatic adenomatosis
UR - http://www.scopus.com/inward/record.url?scp=84943236676&partnerID=8YFLogxK
U2 - 10.1007/s11901-015-0265-7
DO - 10.1007/s11901-015-0265-7
M3 - Article
C2 - 26430609
AN - SCOPUS:84943236676
VL - 14
SP - 139
EP - 143
JO - Current Hepatitis Reports
JF - Current Hepatitis Reports
SN - 1540-3416
IS - 2
M1 - A008
ER -